Final report on the safety assessment of Yarrow (Achillea millefolium) Extract
- PMID: 11558643
- DOI: 10.1080/10915810160233785
Final report on the safety assessment of Yarrow (Achillea millefolium) Extract
Abstract
Yarrow (Achillea Millefolium) Extract is an extract of the yarrow plant, Achillea millefolium, supplied in polypropylene glycol, which is reported to function as a "biological additive" in cosmetic products. Sesquiterpene lactones, polyacetylenes, simple coumarins, and flavonoids have been identified among the many components of A. millefolium. Yarrow Extract was reportedly used in 65 cosmetic formulations. Historically, Yarrow (Achillea Millefolium) Extract was reported to be used at concentrations of < or =25%, but recent data indicate that this ingredient is supplied with actual Yarrow (Achillea Millefolium) Extract content of 2% to 25% and used at concentrations of 0.5% to 10%. Only limited toxicity data were available. Guinea pigs were sensitized to crude extracts of the whole plant and the flowers of A. millefolium. A. millefolium tea was weakly genotoxic in a somatic mutation and recombination test using Drosophila melanogaster. In clinical testing, product formulations containing 0.1% to 0.5% of ingredient that actually contained 2% of Yarrow Extract were generally not irritating. In provocative testing, patients reacted to a Compositae mix that contained yarrow, as well as to yarrow itself. Also in clinical testing, a formulation containing 0.1% Yarrow (Achillea Millefolium) Extract (2% Yarrow in propylene glycol and water) was not a sensitizer in a maximization test and alcoholic extracts of dried leaves and stalks of A. millefolium did not produce a phototoxic response. These data were not considered sufficient to support the safety of this ingredient in cosmetics. The types of data (all testing is to be performed on cosmetic-grade ingredients) still required include (1) ultraviolet (UV) absorption data, if absorption occurs in the UVA or UVB range, photosensitization data are needed; (2) gross pathology and histopathology in skin and other major organ systems associated with repeated exposures; (3) reproductive and developmental toxicity data; (4) two genotoxicity studies, one using a mammalian system, if positive, a 2-year dermal carcinogenicity assay performed using National Toxicology Program (NTP) methods may be needed; and (5) clinical sensitization testing at maximum concentration of use. In the absence of these data, it was concluded that the available data are insufficient to support the safety of Yarrow (Achillea Millefolium) Extract for use in cosmetic products.
Similar articles
-
Final report on the safety assessment of Calendula officinalis extract and Calendula officinalis.Int J Toxicol. 2001;20 Suppl 2:13-20. doi: 10.1080/10915810160233721. Int J Toxicol. 2001. PMID: 11558637 Review.
-
Final report on the safety assessment of Arnica montana extract and Arnica montana.Int J Toxicol. 2001;20 Suppl 2:1-11. doi: 10.1080/10915810160233712. Int J Toxicol. 2001. PMID: 11558636 Review.
-
Safety Assessment of Achillea millefolium as Used in Cosmetics.Int J Toxicol. 2016 Nov;35(3 suppl):5S-15S. doi: 10.1177/1091581816677717. Int J Toxicol. 2016. PMID: 27913788 Review.
-
Final report on the safety assessment of Juniperus communis Extract, Juniperus oxycedrus Extract, Juniperus oxycedrus Tar, Juniperus phoenicea extract, and Juniperus virginiana Extract.Int J Toxicol. 2001;20 Suppl 2:41-56. doi: 10.1080/10915810160233758. Int J Toxicol. 2001. PMID: 11558640 Review.
-
Final report on the safety assessment of Hypericum perforatum extract and Hypericum perforatum oil.Int J Toxicol. 2001;20 Suppl 2:31-9. doi: 10.1080/10915810160233749. Int J Toxicol. 2001. PMID: 11558639 Review.
Cited by
-
The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major.Adv Biomed Res. 2014 Mar 31;3:111. doi: 10.4103/2277-9175.129717. eCollection 2014. Adv Biomed Res. 2014. PMID: 24804185 Free PMC article.
-
N-alkylamide profiling of Achillea ptarmica and Achillea millefolium extracts by liquid and gas chromatography-mass spectrometry.J Pharm Anal. 2017 Feb;7(1):34-47. doi: 10.1016/j.jpha.2016.09.005. Epub 2016 Sep 24. J Pharm Anal. 2017. PMID: 29404016 Free PMC article.
-
Investigation on the Essential Oils of the Achillea Species: From Chemical Analysis to the In Silico Uptake against SARS-CoV-2 Main Protease.Life (Basel). 2023 Jan 30;13(2):378. doi: 10.3390/life13020378. Life (Basel). 2023. PMID: 36836736 Free PMC article.
-
Achillea millefolium capsule improved liver enzymes and lipid profile compared to placebo in patients with type 2 diabetes: a double-blind randomized clinical trial.BMC Nutr. 2025 Jan 24;11(1):21. doi: 10.1186/s40795-025-01005-5. BMC Nutr. 2025. PMID: 39856724 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical